-
Something wrong with this record ?
p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells
L. Křížová, M. Kuchař, H. Petroková, R. Osička, M. Hlavničková, O. Pelák, J. Černý, T. Kalina, P. Malý,
Language English Country Great Britain
Document type Journal Article
Grant support
NV16-27676A
MZ0
CEP Register
Digital library NLK
Full text - Article
NLK
Medline Complete (EBSCOhost)
from 2002-02-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- Lymphocyte Activation immunology MeSH
- Cell Line MeSH
- Th17 Cells immunology metabolism MeSH
- Dendritic Cells immunology metabolism MeSH
- Phagocytes immunology metabolism MeSH
- Interleukin-23 Subunit p19 chemistry metabolism pharmacology MeSH
- Interleukin-23 chemistry metabolism MeSH
- Protein Conformation MeSH
- Humans MeSH
- Macrophages immunology metabolism MeSH
- Models, Molecular MeSH
- Receptors, Interleukin metabolism MeSH
- Recombinant Proteins MeSH
- Signal Transduction MeSH
- T-Lymphocyte Subsets immunology metabolism MeSH
- Protein Binding MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Interleukin-23 (IL-23), a heterodimeric cytokine of covalently bound p19 and p40 proteins, has recently been closely associated with development of several chronic autoimmune diseases such as psoriasis, psoriatic arthritis or inflammatory bowel disease. Released by activated dendritic cells, IL-23 interacts with IL-23 receptor (IL-23R) on Th17 cells, thus promoting intracellular signaling, a pivotal step in Th17-driven pro-inflammatory axis. Here, we aimed to block the binding of IL-23 cytokine to its cell-surface receptor by novel inhibitory protein binders targeted to the p19 subunit of human IL-23. To this goal, we used a combinatorial library derived from a scaffold of albumin-binding domain (ABD) of streptococcal protein G, and ribosome display selection, to yield a collection of ABD-derived p19-targeted variants, called ILP binders. From 214 clones analyzed by ELISA, Western blot and DNA sequencing, 53 provided 35 different sequence variants that were further characterized. Using in silico docking in combination with cell-surface competition binding assay, we identified a group of inhibitory candidates that substantially diminished binding of recombinant p19 to the IL-23R on human monocytic THP-1 cells. Of these best p19-blockers, ILP030, ILP317 and ILP323 inhibited IL-23-driven expansion of IL-17-producing primary human CD4+ T-cells. Thus, these novel binders represent unique IL-23-targeted probes useful for IL-23/IL-23R epitope mapping studies and could be used for designing novel p19/IL-23-targeted anti-inflammatory biologics.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016800
- 003
- CZ-PrNML
- 005
- 20180515103506.0
- 007
- ta
- 008
- 180515s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/08916934.2016.1272598 $2 doi
- 035 __
- $a (PubMed)28100093
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Křížová, Lucie $u a Laboratory of Ligand Engineering , Institute of Biotechnology, Czech Academy of Sciences, v. v. i, BIOCEV Research Center , Vestec , Czech Republic.
- 245 10
- $a p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells / $c L. Křížová, M. Kuchař, H. Petroková, R. Osička, M. Hlavničková, O. Pelák, J. Černý, T. Kalina, P. Malý,
- 520 9_
- $a Interleukin-23 (IL-23), a heterodimeric cytokine of covalently bound p19 and p40 proteins, has recently been closely associated with development of several chronic autoimmune diseases such as psoriasis, psoriatic arthritis or inflammatory bowel disease. Released by activated dendritic cells, IL-23 interacts with IL-23 receptor (IL-23R) on Th17 cells, thus promoting intracellular signaling, a pivotal step in Th17-driven pro-inflammatory axis. Here, we aimed to block the binding of IL-23 cytokine to its cell-surface receptor by novel inhibitory protein binders targeted to the p19 subunit of human IL-23. To this goal, we used a combinatorial library derived from a scaffold of albumin-binding domain (ABD) of streptococcal protein G, and ribosome display selection, to yield a collection of ABD-derived p19-targeted variants, called ILP binders. From 214 clones analyzed by ELISA, Western blot and DNA sequencing, 53 provided 35 different sequence variants that were further characterized. Using in silico docking in combination with cell-surface competition binding assay, we identified a group of inhibitory candidates that substantially diminished binding of recombinant p19 to the IL-23R on human monocytic THP-1 cells. Of these best p19-blockers, ILP030, ILP317 and ILP323 inhibited IL-23-driven expansion of IL-17-producing primary human CD4+ T-cells. Thus, these novel binders represent unique IL-23-targeted probes useful for IL-23/IL-23R epitope mapping studies and could be used for designing novel p19/IL-23-targeted anti-inflammatory biologics.
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a dendritické buňky $x imunologie $x metabolismus $7 D003713
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interleukin-23 $x chemie $x metabolismus $7 D053759
- 650 _2
- $a interleukin-23 - podjednotka p19 $x chemie $x metabolismus $x farmakologie $7 D053760
- 650 _2
- $a aktivace lymfocytů $x imunologie $7 D008213
- 650 _2
- $a makrofágy $x imunologie $x metabolismus $7 D008264
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a fagocyty $x imunologie $x metabolismus $7 D010586
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a konformace proteinů $7 D011487
- 650 _2
- $a receptory interleukinů $x metabolismus $7 D018123
- 650 _2
- $a rekombinantní proteiny $7 D011994
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a T-lymfocyty - podskupiny $x imunologie $x metabolismus $7 D016176
- 650 _2
- $a buňky Th17 $x imunologie $x metabolismus $7 D058504
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kuchař, Milan $u a Laboratory of Ligand Engineering , Institute of Biotechnology, Czech Academy of Sciences, v. v. i, BIOCEV Research Center , Vestec , Czech Republic.
- 700 1_
- $a Petroková, Hana $u a Laboratory of Ligand Engineering , Institute of Biotechnology, Czech Academy of Sciences, v. v. i, BIOCEV Research Center , Vestec , Czech Republic.
- 700 1_
- $a Osička, Radim $u b Laboratory of Molecular Biology of the Bacterial Pathogens , Institute of Microbiology, Czech Academy of Sciences , Prague , Czech Republic.
- 700 1_
- $a Hlavničková, Marie $u a Laboratory of Ligand Engineering , Institute of Biotechnology, Czech Academy of Sciences, v. v. i, BIOCEV Research Center , Vestec , Czech Republic.
- 700 1_
- $a Pelák, Ondřej $u c CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol , Prague , Czech Republic , and.
- 700 1_
- $a Černý, Jiří $u d Laboratory of Biomolecular Recognition , Institute of Biotechnology, Czech Academy of Sciences, v. v. i, BIOCEV Research Center , Vestec , Czech Republic.
- 700 1_
- $a Kalina, Tomáš $u c CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol , Prague , Czech Republic , and.
- 700 1_
- $a Malý, Petr $u a Laboratory of Ligand Engineering , Institute of Biotechnology, Czech Academy of Sciences, v. v. i, BIOCEV Research Center , Vestec , Czech Republic.
- 773 0_
- $w MED00000637 $t Autoimmunity $x 1607-842X $g Roč. 50, č. 2 (2017), s. 102-113
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28100093 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180515103640 $b ABA008
- 999 __
- $a ok $b bmc $g 1300424 $s 1013640
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 50 $c 2 $d 102-113 $e 20170119 $i 1607-842X $m Autoimmunity $n Autoimmunity $x MED00000637
- GRA __
- $a NV16-27676A $p MZ0
- LZP __
- $a Pubmed-20180515